48117_Amneal Code of Conduct-update 2023 R6.indd

31 November 2023 We believe we have a special responsibility to our shareholders and the media to provide accurate, understandable, and timely information about our business so investors and potential investors can make informed business decisions. Amneal stock trades on the New York Stock Exchange (NYSE) and, as such, we are subject to United States securities laws and regulatory authorities. Public Disclosure and Company Records It is our policy that information provided in public communications, including our filings with the United States Securities and Exchange Commission and other regulatory authorities in the countries where we do business, be full, fair, accurate, timely, and understandable. All colleagues, including those involved in the financial disclosure process or who otherwise have access to sensitive and/ or confidential Company information, including the Co-Chief Executive Oficers and Chief Financial Oficer, are responsible for assuring compliance with this policy. All such colleagues are required to be familiar with the disclosure requirements that apply to Amneal in accordance with local laws and regulations. You are prohibited from knowingly misrepresenting, omitting, or causing others to misrepresent or omit, material facts about Amneal to others, whether within or outside Amneal, including Amneal’s independent auditors. Company records are the basis for Amneal’s public disclosures. All records must be complete and accurate. It is a serious violation of the Code of Business Conduct to knowingly misrepresent or falsify information in Company records. Prohibition of Insider Trading The Global Amneal Insider Trading Policy, and regulations of many of the countries in which the Company does business, prohibit any oficer, employee or director from buying or selling stock or securities while in possession of material, non- public information relating to such security, whether the issuer of such security is Amneal or any other company (including, but not limited to, a customer, partner, or supplier of the Company). Oficers, directors, and employees are also prohibited from passing or “tipping” any such material, non-public information along to third parties that trade on such information. Violations of these policies may lead to civil and criminal penalties for both Amneal and the individual. There are no exceptions to these rules, even for transactions that may be justifiable or necessary for independent reasons (e.g., the need to raise money for an emergency expenditure). Information is considered “material non-public information” when the information is not available to the general public and there is a substantial likelihood that a reasonable investor would consider it important in making a decision to buy, sell, or hold a security or if the fact is likely to have a significant efect on the market price of the security. Material information can be positive or negative and can relate to virtually any aspect of a company’s business or to any type of security, debt, or equity. Although this is not a complete list, information about the following matters may be considered to be “material non-public information” until publicly disseminated: • Financial results or forecasts • Earnings or earnings forecasts • Dividends • Significant borrowing or financing developments including pending public sales or oferings of debt or equity securities • Defaults on borrowings • Bankruptcies • Unusual gains or losses in operations • Possible mergers, acquisitions, tender ofers, or dispositions • Significant capital expenditures or borrowings • Major new products or product developments • New product introductions, technological discoveries or regulatory approvals • Clinical trial results • Developments regarding strategic collaborators or the status of regulatory submissions • Significant litigation or regulatory actions • Important business developments such as major contract awards or cancellations • Government inquiries or investigations • Management or control changes